Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 7/2017

14.02.2017 | Original Article

Gardnerella vaginalis population dynamics in bacterial vaginosis

verfasst von: D. W. Hilbert, J. A. Schuyler, M. E. Adelson, E. Mordechai, J. D. Sobel, S. E. Gygax

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Bacterial vaginosis (BV) is the leading cause of vaginal discharge and is associated with the facultative Gram-variable bacterium Gardnerella vaginalis, whose population structure consists of four clades. Our goal was to determine if these clades differ with regard to abundance during BV. We performed a short-term longitudinal study of BV. Patients were evaluated according to the Amsel criteria and Nugent scoring at initial diagnosis, immediately after treatment and at a 40- to 45-day follow-up visit. G. vaginalis clade abundance was determined by quantitative real-time polymerase chain reactions (qPCRs). Among all specimens, the abundance of clades 1 and 4 were higher than that of clades 2 and 3 (P < 0.001). In general, the abundance of each clade increased with the degree of vaginal dysbiosis, as determined by the Nugent score and was greater in women with Amsel 4 compared with those with Amsel 0. Only clade 1 abundance was greater when Amsel 0 or 1 specimens were compared with Amsel 2 or 3 specimens (P < 0.01). Following antimicrobial treatment, abundance of clades 1 (P < 0.001) and 4 (P < 0.05) decreased regardless of the clinical and microbiological outcome, whereas clade 2 only decreased in women who had a sustained treatment response for 40–45 days (P < 0.01). Recurrent BV was characterized by post-treatment increases of clade 1 and 2 (P < 0.01). Clades 1 and 4 predominate in vaginal specimens. Clade abundance differs with regard to the Nugent score, the Amsel criteria, and response to therapy and BV recurrence.
Literatur
1.
Zurück zum Zitat Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE (2007) The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 34(11):864–869CrossRefPubMed Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE (2007) The prevalence of bacterial vaginosis in the United States, 2001–2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 34(11):864–869CrossRefPubMed
2.
Zurück zum Zitat Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV, McNellis D, Regan JA, Carey JC, Klebanoff MA (1995) Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 333(26):1737–1742CrossRefPubMed Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF, Edelman R, Pastorek JG 2nd, Rao AV, McNellis D, Regan JA, Carey JC, Klebanoff MA (1995) Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 333(26):1737–1742CrossRefPubMed
3.
Zurück zum Zitat Larsson PG, Platz-Christensen JJ, Thejls H, Forsum U, Pahlson C (1992) Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. Am J Obstet Gynecol 166(1 Pt 1):100–103CrossRefPubMed Larsson PG, Platz-Christensen JJ, Thejls H, Forsum U, Pahlson C (1992) Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. Am J Obstet Gynecol 166(1 Pt 1):100–103CrossRefPubMed
4.
Zurück zum Zitat Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J (1999) Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180(6):1863–1868CrossRefPubMed Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J (1999) Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180(6):1863–1868CrossRefPubMed
5.
Zurück zum Zitat Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C, Fairley CK, Chen MY, Bradshaw C (2013) The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One 8(9):e74378CrossRefPubMedPubMedCentral Bilardi JE, Walker S, Temple-Smith M, McNair R, Mooney-Somers J, Bellhouse C, Fairley CK, Chen MY, Bradshaw C (2013) The burden of bacterial vaginosis: women’s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLoS One 8(9):e74378CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Gardner HL, Dukes CD (1955) Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol 69(5):962–976CrossRefPubMed Gardner HL, Dukes CD (1955) Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis. Am J Obstet Gynecol 69(5):962–976CrossRefPubMed
8.
Zurück zum Zitat Schwebke JR, Muzny CA, Josey WE (2014) Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J Infect Dis 210(3):338–343CrossRefPubMed Schwebke JR, Muzny CA, Josey WE (2014) Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J Infect Dis 210(3):338–343CrossRefPubMed
9.
Zurück zum Zitat Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D (2008) Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis 47(1):33–43CrossRefPubMed Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D (2008) Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis 47(1):33–43CrossRefPubMed
10.
Zurück zum Zitat Hilbert DW, Smith WL, Paulish-Miller TE, Chadwick SG, Toner G, Mordechai E, Adelson ME, Sobel JD, Gygax SE (2016) Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis. Diagn Microbiol Infect Dis 86(2):231–242CrossRefPubMed Hilbert DW, Smith WL, Paulish-Miller TE, Chadwick SG, Toner G, Mordechai E, Adelson ME, Sobel JD, Gygax SE (2016) Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis. Diagn Microbiol Infect Dis 86(2):231–242CrossRefPubMed
11.
Zurück zum Zitat Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, Marrazzo JM, Fredricks DN (2010) Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 5(4):e10197CrossRefPubMedPubMedCentral Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, Marrazzo JM, Fredricks DN (2010) Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 5(4):e10197CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Swidsinski A, Doerffel Y, Loening-Baucke V, Swidsinski S, Verstraelen H, Vaneechoutte M, Lemm V, Schilling J, Mendling W (2010) Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Invest 70(4):256–263CrossRefPubMed Swidsinski A, Doerffel Y, Loening-Baucke V, Swidsinski S, Verstraelen H, Vaneechoutte M, Lemm V, Schilling J, Mendling W (2010) Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Invest 70(4):256–263CrossRefPubMed
13.
Zurück zum Zitat Gilbert NM, Lewis WG, Lewis AL (2013) Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis. PLoS One 8(3):e59539CrossRefPubMedPubMedCentral Gilbert NM, Lewis WG, Lewis AL (2013) Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis. PLoS One 8(3):e59539CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Piot P, Van Dyck E, Peeters M, Hale J, Totten PA, Holmes KK (1984) Biotypes of Gardnerella vaginalis. J Clin Microbiol 20(4):677–679PubMedPubMedCentral Piot P, Van Dyck E, Peeters M, Hale J, Totten PA, Holmes KK (1984) Biotypes of Gardnerella vaginalis. J Clin Microbiol 20(4):677–679PubMedPubMedCentral
15.
Zurück zum Zitat Ahmed A, Earl J, Retchless A, Hillier SL, Rabe LK, Cherpes TL, Powell E, Janto B, Eutsey R, Hiller NL, Boissy R, Dahlgren ME, Hall BG, Costerton JW, Post JC, Hu FZ, Ehrlich GD (2012) Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol 194(15):3922–3937CrossRefPubMedPubMedCentral Ahmed A, Earl J, Retchless A, Hillier SL, Rabe LK, Cherpes TL, Powell E, Janto B, Eutsey R, Hiller NL, Boissy R, Dahlgren ME, Hall BG, Costerton JW, Post JC, Hu FZ, Ehrlich GD (2012) Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol 194(15):3922–3937CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Fredricks DN, Fiedler TL, Marrazzo JM (2005) Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353(18):1899–1911CrossRefPubMed Fredricks DN, Fiedler TL, Marrazzo JM (2005) Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353(18):1899–1911CrossRefPubMed
17.
Zurück zum Zitat Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 108 [Suppl 1]:4680–4687CrossRefPubMed Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A 108 [Suppl 1]:4680–4687CrossRefPubMed
18.
Zurück zum Zitat Balashov SV, Mordechai E, Adelson ME, Gygax SE (2014) Identification, quantification and subtyping of Gardnerella vaginalis in noncultured clinical vaginal samples by quantitative PCR. J Med Microbiol 63(Pt 2):162–175CrossRefPubMed Balashov SV, Mordechai E, Adelson ME, Gygax SE (2014) Identification, quantification and subtyping of Gardnerella vaginalis in noncultured clinical vaginal samples by quantitative PCR. J Med Microbiol 63(Pt 2):162–175CrossRefPubMed
19.
Zurück zum Zitat Hilbert DW, Smith WL, Chadwick SG, Toner G, Mordechai E, Adelson ME, Aguin TJ, Sobel JD, Gygax SE (2016) Development and validation of a highly accurate quantitative real-time PCR assay for diagnosis of bacterial vaginosis. J Clin Microbiol 54(4):1017–1024CrossRefPubMedPubMedCentral Hilbert DW, Smith WL, Chadwick SG, Toner G, Mordechai E, Adelson ME, Aguin TJ, Sobel JD, Gygax SE (2016) Development and validation of a highly accurate quantitative real-time PCR assay for diagnosis of bacterial vaginosis. J Clin Microbiol 54(4):1017–1024CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74(1):14–22CrossRefPubMed Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74(1):14–22CrossRefPubMed
21.
Zurück zum Zitat Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29(2):297–301PubMedPubMedCentral Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29(2):297–301PubMedPubMedCentral
23.
Zurück zum Zitat Fredricks DN, Fiedler TL, Thomas KK, Mitchell CM, Marrazzo JM (2009) Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol 47(3):721–726CrossRefPubMedPubMedCentral Fredricks DN, Fiedler TL, Thomas KK, Mitchell CM, Marrazzo JM (2009) Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol 47(3):721–726CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Briselden AM, Hillier SL (1990) Longitudinal study of the biotypes of Gardnerella vaginalis. J Clin Microbiol 28(12):2761–2764PubMedPubMedCentral Briselden AM, Hillier SL (1990) Longitudinal study of the biotypes of Gardnerella vaginalis. J Clin Microbiol 28(12):2761–2764PubMedPubMedCentral
25.
Zurück zum Zitat Aroutcheva AA, Simoes JA, Behbakht K, Faro S (2001) Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clin Infect Dis 33(7):1022–1027CrossRefPubMed Aroutcheva AA, Simoes JA, Behbakht K, Faro S (2001) Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems. Clin Infect Dis 33(7):1022–1027CrossRefPubMed
26.
Zurück zum Zitat Kharsany AB, Hoosen AA, Van den Ende J (1993) Antimicrobial susceptibilities of Gardnerella vaginalis. Antimicrob Agents Chemother 37(12):2733–2735CrossRefPubMedPubMedCentral Kharsany AB, Hoosen AA, Van den Ende J (1993) Antimicrobial susceptibilities of Gardnerella vaginalis. Antimicrob Agents Chemother 37(12):2733–2735CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT (2002) In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis. Antimicrob Agents Chemother 46(12):3995–3996CrossRefPubMedPubMedCentral Goldstein EJ, Citron DM, Merriam CV, Warren YA, Tyrrell KL, Fernandez HT (2002) In vitro activities of Garenoxacin (BMS 284756) against 108 clinical isolates of Gardnerella vaginalis. Antimicrob Agents Chemother 46(12):3995–3996CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Schuyler JA, Mordechai E, Adelson ME, Sobel JD, Gygax SE, Hilbert DW (2016) Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn Microbiol Infect Dis 84(1):1–3CrossRefPubMed Schuyler JA, Mordechai E, Adelson ME, Sobel JD, Gygax SE, Hilbert DW (2016) Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn Microbiol Infect Dis 84(1):1–3CrossRefPubMed
29.
Zurück zum Zitat Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, Martin DH (2004) Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 4:5CrossRefPubMedPubMedCentral Ferris MJ, Masztal A, Aldridge KE, Fortenberry JD, Fidel PL Jr, Martin DH (2004) Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 4:5CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Criswell BS, Ladwig CL, Gardner HL, Dukes CD (1969) Haemophilus vaginalis: vaginitis by inoculation from culture. Obstet Gynecol 33(2):195–199PubMed Criswell BS, Ladwig CL, Gardner HL, Dukes CD (1969) Haemophilus vaginalis: vaginitis by inoculation from culture. Obstet Gynecol 33(2):195–199PubMed
31.
Zurück zum Zitat Spiegel CA, Amsel R, Eschenbach D, Schoenknecht F, Holmes KK (1980) Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 303(11):601–607CrossRefPubMed Spiegel CA, Amsel R, Eschenbach D, Schoenknecht F, Holmes KK (1980) Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 303(11):601–607CrossRefPubMed
Metadaten
Titel
Gardnerella vaginalis population dynamics in bacterial vaginosis
verfasst von
D. W. Hilbert
J. A. Schuyler
M. E. Adelson
E. Mordechai
J. D. Sobel
S. E. Gygax
Publikationsdatum
14.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2017
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-2933-8

Weitere Artikel der Ausgabe 7/2017

European Journal of Clinical Microbiology & Infectious Diseases 7/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.